Publications by authors named "David Gancberg"

Claim this Profile
T
Twenty Years of European Union Support to Gene Therapy and Gene Transfer.
David Gancberg

Hum Gene Ther· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities for vaccine research in Europe.
David Gancberg, Arnd Hoeveler, Alessandra Martini, Ruxandra Draghia-Akli

Hum Vaccin Immunother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: Gene Therapy and Gene Transfer Projects of the 7th Framework Programme for Research and Technological Development of the European Union (Second Part).
David Gancberg, Arnd Hoeveler, Ruxandra Draghia-Akli

Hum Gene Ther Clin Dev· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: gene and cell therapy projects of the seventh framework program.
David Gancberg, Irene Norstedt, Ruxandra Draghia-Akli

Hum Gene Ther Clin Dev· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene and cell therapy funding opportunities in horizon 2020: an overview for 2014-2015.
David Gancberg, Ruxandra Draghia-Akli

Hum Gene Ther· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Union support of gene therapy research: a success story.
David Gancberg, Charles Kessler, Arnd Hoeveler, Ruxandra Draghia-Akli

Mol Ther· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleic acid reference materials (NARMs): definitions and issues.
Deborah A Payne, Cyril D S Mamotte, David Gancberg, Mario Pazzagli, Ron H N van Schaik

Clin Chem Lab Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for the development of a reference method for sequencing of haploid DNA--an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics, International Federation of Clinical Chemistry and Laboratory Medicine.
François Rousseau, David Gancberg, Heinz Schimmel, Michael Neumaier, Alexandre Bureau

Clin Chem Lab Med· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European external quality control study on the competence of laboratories to recognize rare sequence variants resulting in unusual genotyping results.
János Márki-Zay, Christoph L Klein, David Gancberg, Heinz G Schimmel, László Dux

Clin Chem· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Certification of reference materials for detection of the human prothrombin gene G20210A sequence variant.
David Gancberg, Philippe Corbisier, Nele Meeus, Janos Marki-Zay, Christine Mannhalter

Clin Chem Lab Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Class III beta-tubulin isotype predicts response in advanced breast cancer patients randomly treated either with single-agent doxorubicin or docetaxel.
Carlos M Galmarini, Isabelle Treilleux, Fatima Cardoso, Chantal Bernard-Marty, Virginie Durbecq, David Gancberg

Clin Cancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of comparability in amplified fragment length polymorphism profiling using a simple model system.
Lina Partis, Malcolm Burns, Koichi Chiba, Philippe Corbisier, David Gancberg

Electrophoresis· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation.
Christoph L Klein, János Márki-Zay, Philippe Corbisier, David Gancberg, Susan Cooper

Clin Chem Lab Med· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative determination of Roundup Ready soybean (Glycine max) extracted from highly processed flour.
Philippe Corbisier, Stefanie Trapmann, David Gancberg, Liesbeth Hannes, Pierre Van Iwaarden

Anal Bioanal Chem· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncoselective parvoviral vector-mediated gene therapy of cancer.
Marc Zeicher, Pierre Spegelaere, Marie Horth, David Gancberg, Abdelatif Karim

Oncol Res· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study.
Chantal Bernard-Marty, Isabelle Treilleux, Charles Dumontet, Fatima Cardoso, Arlette Fellous, David Gancberg

Clin Breast Cancer· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practice.
Denis Larsimont, Angelo Di Leo, Ghizlane Rouas, Marianne Paesmans, Fabiano Ferreira-Filho, David Gancberg

Anticancer Res· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing.
David Gancberg, Tero Järvinen, Angelo di Leo, Ghizlane Rouas, Fatima Cardoso

Breast Cancer Res Treat· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.
Angelo Di Leo, David Gancberg, Denis Larsimont, Minna Tanner, Tero Jarvinen

Clin Cancer Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis